JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$16.06
-2.12 (-11.66%)
Open$18.18
Previous Close$18.18
Day High$18.24
Day Low$16.02
52W High$35.34
52W Low$12.12
Volume—
Avg Volume692.5K
Market Cap1.08B
P/E Ratio—
EPS$-1.64
SectorBiotechnology
Analyst Ratings
Strong Buy
25 analysts
Price Target
+205.7% upside
Current
$16.06
$16.06
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.83M | 10.30M | 135.69M |
| Net Income | -123,059,141 | -105,358,853 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -168,562,030 | -152,334,406 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |